Global Routine Vaccination Coverage - 2017

Kristin VanderEnde, Marta Gacic-Dobo, Mamadou S Diallo, Laura M Conklin, Aaron S Wallace, Kristin VanderEnde, Marta Gacic-Dobo, Mamadou S Diallo, Laura M Conklin, Aaron S Wallace

Abstract

Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. This report updates previous reports (2,3) and presents global, regional, and national vaccination coverage estimates and trends as of 2017. It also describes the number of infants surviving to age 1 year (surviving infants) who did not receive the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP3), a key indicator of immunization program performance (4,5), with a focus on the countries with the highest number of children who did not receive DTP3 in 2017. Based on the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) estimates, global DTP3 coverage increased from 79% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). In 2017, among the 19.9 million children who did not receive DTP3 in the first year of life, 62% (12.4 million) lived in 10 countries. From 2007 to 2017, the number of children who had not received DTP3 decreased in five of these 10 countries and remained stable or increased in the other five. Similar to DTP3 coverage, global coverage with the first measles-containing vaccine dose (MCV1) increased from 80% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). Coverage with the third dose of polio vaccine (Pol3) has remained stable at 84%-85% since 2010. From 2007 to 2017, estimated global coverage with the second MCV dose (MCV2) increased from 33% to 67%, as did coverage with the completed series of rotavirus (2% to 28%), pneumococcal conjugate (PCV) (4% to 44%), rubella (26% to 52%), Haemophilus influenzae type b (Hib) (25% to 72%) and hepatitis B (HepB) (birth dose: 24% to 43%; 3-dose series: 63% to 84%) vaccines. Targeted, context-specific strategies are needed to reach and sustain high vaccination coverage, particularly in countries with the highest number of unvaccinated children.

Conflict of interest statement

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Number of surviving infants and children who did not receive DTP3 (unvaccinated) by age 1 year — India and Nigeria, 1997–2017 Abbreviation: DTP3 = third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine. * Number of children surviving to age 1 year. † The number of children not receiving DTP3 is calculated based on yearly estimates of the number of surviving infants and DTP3 coverage rates.

References

    1. World Health Organization. Global vaccine action plan 2011–2020. Geneva, Switzerland: World Health Organization; 2013.
    1. Casey RM, Dumolard L, Danovaro-Holliday MC, et al. Global routine vaccination coverage, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1270–3. 10.15585/mmwr.mm6545a5
    1. Feldstein LR, Mariat S, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS. Global routine vaccination coverage, 2016. MMWR Morb Mortal Wkly Rep 2017;66:1252–5. 10.15585/mmwr.mm6645a3
    1. Okwo-Bele JM, Cherian T. The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine 2011;29(Suppl 4):D74–9. 10.1016/j.vaccine.2012.01.080
    1. Burton A, Monasch R, Lautenbach B, et al. WHO and United Nations Children’s Fund estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009;87:535–41. 10.2471/BLT.08.053819
    1. The World Bank. World Bank country and lending groups. New York, NY: The World Bank; 2016.
    1. World Health Organization. Immunization, vaccines and biologicals—data, statistics and graphs. Geneva, Switzerland: World Health Organization; 2018. .
    1. Wallace AS, Ryman TK, Dietz V. Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives. J Infect Dis 2014;210(Suppl 1):S514–22. 10.1093/infdis/jiu108

Source: PubMed

3
Se inscrever